Filters
CAR-T cell therapy is one of the newest and most promising treatments available for blood cancer. These treatments aid in the battle against cancer by utilizing your body's immune system.
Factors affecting the cost of CAR-T:
- Development and Manufacturing Costs: The scientific manipulation of a patient's T-cells to generate chimeric antigen receptors that specifically target cancer cells is the basis for CAR-T treatment. CAR-T cell development and production are intricate and costly processes requiring specialized laboratory equipment and methods. The total cost of CAR-T therapy is greatly increased by these up-front expenses.
- Type of Cancer: Certain cancers, including some forms of leukemia and lymphoma, have been approved for treatment with CAR-T therapy. The cost of CAR-T therapy and the intricacy of the treatment regimen may vary depending on the particular form of cancer being treated.
- Development and Manufacturing Costs: The scientific manipulation of a patient's T-cells to generate chimeric antigen receptors that specifically target cancer cells is the basis for CAR-T treatment. CAR-T cell development and production are intricate and costly processes requiring specialized laboratory equipment and methods. The total cost of CAR-T therapy is greatly increased by these up-front expenses.
- Type of Cancer: Certain cancers, including some forms of leukemia and lymphoma, have been approved for treatment with CAR-T therapy. The cost of CAR-T therapy and the intricacy of the treatment regimen may vary depending on the particular form of cancer being treated.
- Post-treatment Monitoring and Support: After receiving CAR-T therapy, patients need to be closely watched for any adverse effects, such as neurotoxicity and cytokine release syndrome (CRS), and their response to treatment needs to be continuously assessed. The total cost of treatment should account for the expenses of supportive care, side effect control, and monitoring following treatment.
- Geographic Location: The cost of healthcare varies by nation and location. Healthcare expenditures, even those for cutting-edge treatments like CAR-T therapy, are typically higher in urban areas or in locations with higher cost of living.
- Supply and Demand Dynamics: CAR-T therapy availability may be restricted in some areas, and treatment costs may be impacted by supply and demand dynamics. The possibility exists that treatment prices could go down over time as more facilities start to provide CAR-T therapy and as manufacturing procedures become more efficient.
| Country | Cost | Local_currency |
|---|---|---|
| United Kingdom | USD 373000 | 294670 |
| Turkey | USD 443200 | 13358048 |
| Spain | USD 375000 | 345000 |
| United States | USD 289550 | 289550 |
| Singapore | USD 251388 | 336860 |
CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.
This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.
Classification:
CAR T cell therapy is classified as follows:
- Structure-based classification:
- First-generation CAR T-cells: These CAR T-cells typically consist of an antigen-binding domain (single-chain variable fragment, scFv) linked to a T-cell activation domain, such as the CD3ζ chain. They lack additional co-stimulatory domains.
- Second-generation CAR T-cells: These CAR T-cells include an additional co-stimulatory domain, such as CD28 or 4-1BB (CD137), along with the CD3ζ chain. The presence of co-stimulatory domains enhances T-cell activation and persistence.
- Third-generation CAR T-cells: These CAR T-cells incorporate two co-stimulatory domains along with the CD3ζ chain, aiming to further enhance T-cell function and anti-tumor activity.
Antigen-based classification: It includes
- CD19-targeted CAR T-cells: CD19 is a common target for CAR T-cell therapy and is used in the treatment of B-cell malignancies such as acute lymphoblastic leukemia (ALL) and certain types of lymphoma.
- Other antigen-targeted CAR T-cells: CAR T-cells can be engineered to target a variety of antigens expressed on cancer cells, including but not limited to BCMA (B-cell maturation antigen), CD22, CD30, and EGFRvIII.
CAR T-cell therapy is primarily used to treat blood cancers, such as multiple myeloma, large B-cell lymphoma, and B-cell acute lymphoblastic leukaemia. The patient's own T cells are reprogrammed to identify and destroy cancer cells, cause remission, enhance survival, and have a plan B in case other treatments fail.
Patients with blood cancers who relapsed or are refractory must consult an oncologist to determine candidacy for CAR T therapy, especially if they have failed to respond to traditional treatments (i.e., chemotherapy, radiation, or stem cell transplant). Evaluation is warranted for symptoms such as loss of weight, swelling of lymph nodes, recurrent infection, chronic fatigue, or spontaneous bruising.
Screening tests consist of imaging, bone marrow biopsy, and blood work.Leukapheresis is utilised to harvest T cells from the patient's blood for T-cell collection.Bridging therapy: Certain patients receive chemotherapy while waiting for CAR T cells to be produced.Lymphodepleting chemotherapy is administered before the injection to make room for CAR T cells. The patients should plan for potential hospitalisation, designate caretakers, and discuss long-term follow-up and expected adverse effects with the medical team.
- T-cell harvesting: T cells are removed from the patient's blood by processing.
- Genetic alteration: T cells are designed in the laboratory to express CAR proteins targeting cancer cells.
- Expansion: Modified T cells are expanded to therapeutic levels.
- Infusion: Patient receives an intravenous infusion of CAR T cells.
- Monitoring: Intensive monitoring, often in the hospital, for side effects and reactions.
The whole process, from cell harvesting to infusion, can take three to six weeks. The infusion itself takes a few hours to a few minutes, but for at least one week following the infusion, close monitoring is required, and there will be frequent follow-ups for several months.
- Cytokine Release Syndrome (CRS)
- Neurotoxicity
- Infections
- Low blood counts
- Relapse or non-response
One of the newer treatment options for some blood cancers is CAR T-cell therapy. It is utilised when other treatments are not working or the cancer recurs. CAR T-cell therapy has the potential to cure many blood cancers and extend life in most cases.
Recovery involves managing side effects like CRS and neurotoxicity, monitoring blood levels, and avoiding infections. Laboratory testing, imaging, and monitoring for late issues like hypogammaglobulinemia or relapse are all included in long-term follow-up.
The nature of the cancer, the burden of the disease, and an individual's response all impact success. For example, in pediatric acute lymphoblastic leukaemia, complete remission rates are more than 80%. However, relapse is always a risk, and long-term success is variable.
Would you like some help? We are available.
Get Help Explore Hospitals ( 77 )
Vinmec Can Tho Hospital
Can Tho, Vietnam
- Located in the heart of Can Tho city, it addresses the growing healthcare needs of the Mekong Delta region.
- Regional access to international-standard medical services was limited, especially in southern Vietnam.
- Rising demand for modern infrastructure and specialised healthcare due to population growth and urbanisation.
- Established as the 9th hospital in the Vinmec Healthcare System, covering 41,000+ ? with six floors and 155 beds.
- Launched with 21 medical specialities and centres, supported by advanced medical equipment and highly qualified personnel.
- Implemented cutting-edge technology (e.g., 3.0 Tesla MRI, 512-slice CT scanner, digital mammography, AI-integrated mobile X-ray).
- Rolled out incentive programs for community engagement (e.g., free health screenings, discounted cancer checkups).
- Built an expert-led service model focused on early screening, precise diagnosis, and modern treatment protocols.
- To deliver world-class healthcare locally and reduce the need for patients to travel to major cities for treatment.
- To improve public health outcomes in the Mekong Delta by combining advanced technology with expert care.
- To align with Vinmec's mission of providing high-quality, patient-centred care and promoting innovation in Vietnamese healthcare
Fortis Hiranandani Hospital
Mumbai, India
- Fortis Hiranandani Hospital, Vashi, Navi Mumbai, is a leading NABH-accredited multi-super speciality hospital offering advanced tertiary care with over 150 beds.
- The hospital is known for clinical excellence in Cardiac Sciences, Oncology, Neurology, Orthopaedics, Organ Transplants, Urology, Gastroenterology, and Critical Care.
- With a strong team of experienced doctors, modern medical technology, and international patient services, the hospital provides comprehensive and patient-focused treatment.
- It maintains high standards of safety, hygiene, and quality care, making it a trusted healthcare destination in the Mumbai Metropolitan Region.
Fortis Hospital, Shalimar Bagh
Delhi, India
4.5 ( 4 Reviews )
- Fortis Hospital, Shalimar Bagh, New Delhi, is a leading multi-super-speciality hospital established in 2010, known for advanced medical technology and compassionate patient care.
- The hospital has 375 beds, including 166 ICU beds, and features 10 modular operating theatres along with specialised ICUs and Level III NICU/PICU. Fortis Shalimar Bagh offers care across Cardiology, Neurosciences, Oncology, Orthopaedics, Transplants, Urology, and Mother & Child Health, supported by NABH and NABL accreditation.
- Equipped with cutting-edge technology like the Da Vinci Surgical Robot, PET-CT Scanner, and CORI Robotic System, the hospital is recognised for excellence in treatment outcomes, patient comfort, and multidisciplinary care, making it a trusted destination for both domestic and international patients.
Max Smart Super Speciality Hospital
Delhi, India
3.9 ( 2 Reviews )
- Max Smart Super Speciality Hospital, Saket, New Delhi, is a 250-bed tertiary care hospital known for advanced medical technology and patient-centred care.
- The hospital offers services across 22+ specialities, including Cardiac Sciences, Orthopaedics, Urology, Neurology, Neurosurgery, Paediatrics, Obstetrics, and Gynaecology.
- It is a regional hub for complex procedures such as neurovascular interventions, targeted cancer treatments, heart surgeries, kidney and liver transplants, and bariatric care.
- Equipped with a 3.0 Tesla MRI, 256 Slice CT Angio, Cath Labs, Digital Orthopaedic Suite, and advanced diagnostic tools, and supported by 275+ doctors and 606+ trained staff, Max Smart Saket provides high-quality, multidisciplinary care for domestic and international patients.
Thumbay University Hospital, Ajman
Ajman, United Arab Emirates
4.1 ( 1 Reviews )
Types of CAR-T in Thumbay University Hospital, Ajman and its associated cost
| Treatment Option | Approximate Cost Range (USD) | Approximate Cost Range (AED) |
|---|---|---|
| CAR-T | 137318 - 445241 | 484621 - 1672954 |
- Address: Thumbay University Hospital - Ajman - United Arab Emirates
- Facilities related to Thumbay University Hospital, Ajman: Online Doctor Consultation, Post operative followup, Mobility Accessible Rooms, Rehabilitation, Air Ambulance
Meliva Kardiolita Hospital, Kaunas
Kaunas, Lithuania
Apart from in-detail treatment procedures available, Kardiolita Hospital, Kaunas located in Kaunas, Lithuania has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals. Also listed below are some of the most prominent infrastructural details:
- An outpatient department, 56-beds for inpatients
- 13 advanced operation theatres
- 24-hour intensive care unit
- Emergency Department
- Gynecology Center
- Vascular Center
- ENT Center
- Neurology Center
- General and Abdominal Surgery Center
- The staff also takes care of your air travel and pick & drop facility
- Gynecology Center
- Vascular Center
- ENT Center
- Neurology Center
- General and Abdominal Surgery Center
- The staff also takes care of your air travel and pick & drop facility
Max Super Specialty Hospital, Shalimar Bagh
Delhi, India
- Max Super Speciality Hospital, Shalimar Bagh, is a 402-bed quaternary-care hospital in New Delhi, offering advanced treatment across 37+ specialities, including Cancer, Cardiac, Neurosciences, Gastroenterology, Orthopaedics, and Renal Transplant.
- Equipped with state-of-the-art technology and a team of highly skilled doctors and nurses, the hospital provides complex procedures, minimally invasive surgeries, and targeted cancer treatments, making it one of India’s leading healthcare destinations.
Amrita Hospital
Faridabad, India
Founded in 1998 by Mata Amritanandamayi (Amma), the Amrita Institute of Medical Sciences and Research Centre is one of India’s leading healthcare institutions, accredited by ISO, NABH, and NABL. With 2 branches, 7 medical colleges, and a network of 800+ doctors and 2,600+ beds, it offers comprehensive care across 81 specialties and 12 super-specialty departments, supported by 60+ modern operating theatres and 534 critical care beds. The Faridabad campus, a world-class multispeciality facility, houses advanced centers for oncology, neurosciences, cardiac sciences, gastro-sciences, mother and child care, and trauma care, along with India’s most comprehensive infectious disease unit. Guided by a mission of compassion and innovation, Amrita Hospitals combine cutting-edge medicine with humanitarian service to empower communities and promote holistic well-being.
Rajagiri Hospital
Kochi, India
- Rajagiri Hospital, Kochi, Kerala, is a leading multi-speciality tertiary care hospital known for providing world-class medical services with advanced technology and compassionate care.
- Accredited by JCI, NABH, and NABL, the hospital offers comprehensive treatment across specialities like Cardiology, Oncology, Neurology, Gastroenterology, Orthopaedics, Nephrology, Urology, and Paediatrics, making it a trusted healthcare destination in South India.
Bukit Tinggi Medical Centre
Kuala Lumpur, Malaysia
As a tertiary care hospital, Bukit Tinggi Medical Centre (BTMC) is committed to providing high-quality, reasonably priced healthcare.
With a focus on patient care and a team of committed medical professionals and personnel, we want to realize our ambition of becoming Klang's go-to healthcare provider. Orthopedics, neurosurgery, cardiac surgery, obstetrics and gynecology, pediatrics and rehabilitation, aesthetic surgery, and other specialties are all part of our multidisciplinary team approach. Additionally, BTMC has a Health Screening Center that provides a range of health packages to meet the requirements of diverse patient types.
Need Some Advice From Our Experts?
Request a Call Back Now!
Our team of healthcare experts would be happy to assist you
+99Process Involved for CAR-T
- Preoperative Stage: An assessment of the patient's medical history, including testing to determine eligibility for CAR-T therapy and identify the target antigen on cancer cells.
- Treatment Plan Discussion: An oncologist discusses the procedure of CAR-T therapy, including potential dangers, advantages, and side effects.
- Therapeutic Stage: T-cells are extracted from the patient, modified in the lab to express a chimeric antigen receptor (CAR), and reintroduced into the patient to target and destroy cancer cells.
- Postoperative Phase: Closely monitor for side effects. Follow-ups are scheduled regularly to check the response and treat any complications.
- Cancer patients, especially those suffering from blood cancers like leukemia, lymphoma, and multiple myeloma.
- Patients who have not responded to previous therapies, such as chemotherapy or radiation.
- Patients in good overall health with a functioning immune system.
- Individuals who have specific genetic markers that qualify them for CAR-T treatment.
- Targeted Action: CAR-T treatment specifically targets cancer cells, increasing efficacy while minimising damage to healthy cells.
- Potential for Remission: Can result in long-term remission, even in people with difficult-to-treat cancer.
- Minimally Invasive: The treatment consists mainly of an outpatient procedure for T-cell collection, with the therapy provided via infusion.
- Fill out the inquiry form: Fill out the form to provide us with the relevant information about your condition.
- Consult with Our Healthcare Expert: One of our qualified specialists will contact you for a consultation.
- Receive a Detailed Treatment Plan: After examining your situation, we will provide you with a detailed treatment plan that includes expert views and cost breakdowns for various choices.
- Choose your preferred option: Choose the treatment option that suits you the best.
